Journal
RADIOTHERAPY AND ONCOLOGY
Volume 88, Issue 2, Pages 177-182Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.radonc.2008.03.005
Keywords
anaplastic glioma; radiotherapy; chemotherapy; outcome
Ask authors/readers for more resources
Outcome after radiochemotherapy (RCHT) with temozolomide (TMZ) versus radiotherapy (RT) for WHO grade III astrocytic tumors was evaluated. No significant difference in overall survival or progression-free survival between both groups was calculated. RCHT seems not to result in an improved outcome. Further randomized studies are needed to support these results. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available